The company behind blood pressure medication tablets has expanded a recall for two products after trace amounts of a possible cancer-causing ingredient was detected in the tablets.
Torrent Pharmaceuticals Limited said its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, are affected by the recall.
FROZEN TUNA SOLD IN NEW YORK, CONNECTICUT RECALLED AMID SALMONELLA OUTBREAK
The ingredient detected was identified as N-Methylnitrosobutyric acid (NMBA), a known animal and potential human carcinogen. The company said the recall only affects products found to have more than the FDA-allowable amount of NMBA.
The company issued an initial recall in December, followed by two more in January and March. The fourth recall includes an additional 36 lots of Losartan Potassium Tablets USP and 68 lots of Losartan Potassium/hydrochlorothiazide Tablets, USP.
